These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3886306

  • 1. Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.
    Kostka-Trabkowa E, Dembińska-Kieć A, Grodzińska L, Bieroń K, Gryglewski RJ.
    Curr Med Res Opin; 1985; 9(6):407-15. PubMed ID: 3886306
    [Abstract] [Full Text] [Related]

  • 2. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
    Chyzy R, Lukjan H, Rość D, Bielawiec M, Sawicka J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):549-54. PubMed ID: 2446996
    [Abstract] [Full Text] [Related]

  • 3. [Pentoxifylline and prostaglandins].
    Poggesi L, Boddi M, Scarti L, Masotti G.
    Ric Clin Lab; 1988; 18 Suppl 2():37-46. PubMed ID: 2854659
    [No Abstract] [Full Text] [Related]

  • 4. Mechanism of the potentiation of thrombolysis by pentoxifylline (Trental).
    Ambrus JL, Ambrus CM, Mahfzah M, Markus JA, Klein E, Gastpar H.
    J Med; 1987; 18(5-6):265-76. PubMed ID: 3505256
    [Abstract] [Full Text] [Related]

  • 5. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K, Zebrowski M, Kancelarczyk WL, Rymaszewski Z.
    Pol Tyg Lek; 1988 Aug 22; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract] [Full Text] [Related]

  • 6. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
    Manrique RV, Manrique V.
    Angiology; 1987 Feb 22; 38(2 Pt 1):101-8. PubMed ID: 3030162
    [Abstract] [Full Text] [Related]

  • 7. [Use of pentoxifylline (trental) to correct microcirculatory disorders in patients with atherosclerosis of peripheral arteries].
    Atroshchenko ES.
    Kardiologiia; 1986 Dec 22; 26(12):106-8. PubMed ID: 3550207
    [No Abstract] [Full Text] [Related]

  • 8. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
    Strano A, Davi G, Avellone G, Novo S, Pinto A.
    Angiology; 1984 Jul 22; 35(7):459-66. PubMed ID: 6380350
    [Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A, Davì G, Novo S, Avellone G, Pinto A.
    Ric Clin Lab; 1981 Jul 22; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
    Berent H, Kancelarczyk WL, Zebrowski M, Uchman B.
    Pol Tyg Lek; 1988 Jun 13; 43(24):776-8. PubMed ID: 3237518
    [No Abstract] [Full Text] [Related]

  • 11. [Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
    Cavaller JM, Samper JC.
    Med Monatsschr; 1976 Jul 13; 30(7):323-6. PubMed ID: 790140
    [No Abstract] [Full Text] [Related]

  • 12. Drug stimulated prostacyclin release.
    Weithmann KU.
    Ric Clin Lab; 1981 Jul 13; 11 Suppl 1():209-14. PubMed ID: 6324324
    [Abstract] [Full Text] [Related]

  • 13. Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease.
    Bieroń K, Grodzińska L, Kostka-Trabka E, Gryglewski RJ.
    Wien Klin Wochenschr; 1993 Jul 13; 105(1):7-11. PubMed ID: 8438599
    [Abstract] [Full Text] [Related]

  • 14. [Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
    Beykirch H, Reuter W, Voigt H, Herrmann W.
    Z Gesamte Inn Med; 1989 Feb 01; 44(3):77-9. PubMed ID: 2728555
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of vascular diseases of the extremities using pentoxifylline].
    Di Perri T.
    Ric Clin Lab; 1988 Feb 01; 18 Suppl 2():49-56. PubMed ID: 3073515
    [No Abstract] [Full Text] [Related]

  • 16. Study of platelet aggregation in vivo. III. Effect of pentoxifylline.
    Gastpar H, Ambrus JL, Ambrus CM, Spavento P, Weber FJ, Thurber LE.
    J Med; 1977 Feb 01; 8(3-4):191-7. PubMed ID: 407320
    [Abstract] [Full Text] [Related]

  • 17. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
    Ott E, Lechner H, Fazekas F.
    Eur Neurol; 1983 Feb 01; 22 Suppl 1():105-7. PubMed ID: 6884401
    [Abstract] [Full Text] [Related]

  • 18. Effect of pentoxifylline on platelet aggregation.
    Nenci GG, Gresele P, Agnelli G, Ballatori E.
    Pharmatherapeutica; 1981 Feb 01; 2(8):532-8. PubMed ID: 7255510
    [Abstract] [Full Text] [Related]

  • 19. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
    Weithmann KU, Just M, Schlotte V, Seiffge D.
    Vasa; 1989 Feb 01; 18(4):273-6. PubMed ID: 2514520
    [Abstract] [Full Text] [Related]

  • 20. The treatment of chronic cerebrovascular insufficiency. A double-blind study with pentoxifylline ('Trental' 400).
    Harwart D.
    Curr Med Res Opin; 1979 Feb 01; 6(2):73-84. PubMed ID: 380914
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.